matern
infant
morbid
mortal
obviou
consequ
mani
intrapartum
peripartum
infect
even
infect
produc
observ
matern
symptom
dramat
affect
fetal
intrauterin
growth
develop
despit
advanc
peripartum
care
matern
morbid
mortal
associ
infect
pregnanc
increas
even
develop
countri
recent
publish
data
center
diseas
control
pregnanc
mortal
surveil
system
indic
although
matern
mortal
hemorrhag
embol
anesthesia
declin
unit
state
proport
matern
death
due
infect
increas
infect
account
pregnancyrel
death
overal
abortionrel
death
greatest
infect
risk
found
black
older
women
women
without
prenat
care
women
multipl
pregnanc
unit
state
pregnanc
rate
stabl
increas
group
infect
also
major
caus
morbid
mortal
fetu
newborn
mani
perinat
infect
associ
intrauterin
growth
retard
low
birthweight
caus
fetal
neonat
brain
injuri
infect
particularli
bacteri
vaginosi
chorioamnion
result
preterm
deliveri
liveborn
infant
deliveri
week
gestat
stillbirth
evid
intrauterin
infect
report
spontan
birth
occur
less
week
gestat
time
notabl
rate
preterm
birth
develop
countri
rise
unit
state
increas
develop
countri
infect
due
treponema
pallidum
syphili
toxoplasma
gondii
listeria
monocytogen
parvoviru
hiv
group
b
streptococcu
mycoplasma
spp
ureaplasma
urealyticum
chlamydia
trachomati
organ
associ
chorioamnion
may
caus
stillbirth
pregnanc
overal
greatest
risk
earlier
pregnanc
among
stillbirth
less
week
gestat
infect
estim
caus
comparison
stillbirth
week
stillbirth
week
unit
state
fetal
mortal
rate
less
week
gestat
period
like
associ
infect
declin
sinc
rate
live
birth
fetal
death
even
greater
rate
black
women
highest
risk
highest
rate
live
birth
plu
fetal
death
occur
black
women
global
world
health
organ
estim
perinat
acquir
infect
respons
death
newborn
multitud
immunolog
endocrinolog
metabol
physiolog
anatom
chang
influenc
likelihood
cours
mani
infect
pregnanc
chang
intrins
occur
normal
pregnanc
other
occur
vari
degre
normal
abnorm
pregnanc
chang
immun
respons
infect
inadvert
byproduct
alter
matern
immun
function
essenti
order
initi
sustain
pregnanc
normal
pregnanc
matern
immun
system
must
allow
implant
subsequ
develop
fetal
hemiallograft
evalu
regulatori
role
cell
innat
immun
system
monocyt
nk
cell
dendrit
cell
treg
cell
inhibit
allograft
reject
antitumor
respons
contribut
persist
intracellular
pathogen
leishmania
express
cell
marker
number
circul
matern
treg
increas
throughout
pregnanc
slowli
declin
postpartum
increas
number
treg
cell
found
human
matern
decidua
possibl
respons
increas
progesteron
pregnanc
hormon
chang
nk
cell
popul
also
occur
earli
week
pregnanc
much
earlier
shift
appar
third
trimest
type
type
shift
nk
cell
popul
evidenc
chang
cell
marker
includ
decreas
receptor
express
increas
express
decreas
product
type
cell
increas
regulatori
nk
cell
popul
import
allograft
toler
recent
describ
appear
similar
role
regulatori
nk
cell
protect
fetu
uniqu
immunosuppress
popul
regulatori
nk
cell
report
uteru
pregnant
women
cell
recruit
endometrium
peripher
blood
prolifer
differenti
immunosuppress
cell
decidu
microenviron
cell
inhibitori
receptor
recogn
placent
express
class
antigen
hlac
hlag
hlae
inhibit
matern
nk
cell
activ
shift
pregnanc
favor
type
respons
also
demonstr
circul
dendrit
cell
monocyt
granulocyt
pregnanc
dendrit
cell
decreas
third
trimest
bias
secret
rather
favor
phenotyp
monocyt
granulocyt
primari
effector
cell
innat
immun
system
increas
number
begin
first
trimest
activ
phenotyp
demonstr
vitro
enhanc
phagocytosi
respiratori
burst
activ
monocyt
express
endotoxin
receptor
increas
endotoxininduc
product
late
gestat
monocyt
granulocyt
concentr
decidua
increas
product
cytokin
cytokin
express
increas
labor
may
act
promot
labor
underli
activ
granulocyt
monocyt
potenti
enhanc
cytokin
respons
microbi
pathogen
may
explain
associ
infect
preterm
birth
type
cytokin
environ
monocyt
activ
shift
classic
altern
activ
pattern
expos
type
cytokin
monocyt
express
receptor
broad
specif
foreign
antigen
macrophag
mannos
receptor
result
increas
endocytosi
antigen
present
contrast
function
enhanc
exposur
type
cytokin
nitric
oxid
product
cytotox
lysi
microorgan
reduc
alternativelyactiv
monocyt
promot
type
environ
induc
differenti
cell
cell
l
l
l
macrophag
colonystimul
factor
mcsf
l
vascular
endotheli
growth
factor
vegf
l
l
transform
growth
factorbeta
hormon
l
progesteron
l
estradiol
l
corticotrophin
releas
hormon
l
human
placent
lactogen
syncytiotrophoblast
debrismicroparticl
viral
antigen
noteworthi
herp
simplex
viru
human
cytomegaloviru
disrupt
placent
hlag
express
placenta
produc
number
cytokin
local
immunomodulatori
effect
also
enter
matern
circul
cytokin
includ
immunosuppress
cytokin
plu
enhanc
gener
treg
altern
activ
monocyt
found
amniot
fluid
increas
level
blood
women
week
gestat
placent
produc
cytokin
support
monocyt
activ
includ
macrophag
colonystimul
factor
vascular
endotheli
growth
factor
pregnancyspecif
glycoprotein
later
pregnanc
increas
placent
product
progesteron
estradiol
corticotrophinreleas
hormon
human
placent
lactogen
pregnancyrel
hormon
contribut
system
shift
enhanc
monocyt
respons
review
sack
placenta
also
shed
syncytiothrophoblast
debri
includ
subcellular
microparticl
releas
matern
circul
cocultur
experi
microparticl
stimul
pbmc
monocyt
dendrit
cell
uptak
result
product
minim
promot
type
bia
pregnancyassoci
tissu
amniot
epitheli
cell
decidu
inflammatori
cell
placenta
express
tolllik
receptor
tlr
particularli
tlr
patternrecognit
receptor
recogn
repeat
sequenc
surfac
microorgan
express
tlr
inhibit
estrogen
enhanc
higher
progesteron
level
evid
suggest
express
alter
placent
sampl
acut
chorioamnion
cultur
cell
deriv
normal
firsttrimest
trophoblast
crosslink
promot
cytokin
express
ligat
result
apoptot
cell
death
one
interpret
stimul
tlr
could
way
intrauterin
infect
lead
preterm
labor
intrauterin
growth
retard
spontan
abort
preeclampsia
howev
data
regard
role
receptor
context
pregnanc
still
limit
pregnanc
increas
level
steroid
hormon
cortisol
estrogen
particular
progesteron
found
local
uteru
placenta
circul
pregnancyassoci
steroid
modul
gener
surviv
activ
variou
immun
cell
avail
data
come
murin
model
mice
pregnanc
steroid
induc
thymic
involut
mark
shrinkag
cortex
loss
cell
concurr
expans
medulla
product
cell
review
clark
kendal
progesteron
major
influenc
lymphocyt
product
act
intracellular
receptor
thymic
epithelium
downregul
product
b
cell
bone
marrow
steroid
hormon
also
decreas
number
circul
lymphocyt
induc
apoptot
cell
death
although
limit
direct
evid
human
pregnanc
similar
effect
describ
mani
anim
suggest
mechan
conserv
glucocorticoid
progesteron
influenc
function
lymphocyt
stimul
suppress
product
vitro
progesteron
influenc
even
establish
clone
shift
produc
cytokin
progesteron
also
act
indirectli
stimul
progesteronerespons
tissu
produc
pinduc
block
factor
pibf
induc
product
cytokin
leukemia
inhibitori
factor
mcsf
increas
b
cell
antibodi
product
suppress
nk
function
inhibit
cytotox
block
degranul
perforin
releas
inhibit
transform
lymphocyteactiv
killer
cell
progesteron
act
uteru
enhanc
home
nk
cell
upregul
placent
express
hlag
tlr
estrogen
contribut
modul
immun
respons
stimul
prolifer
differ
cell
popul
treg
cell
steroid
hormon
also
promot
altern
activ
monocyt
shift
toward
antigen
present
immun
toler
impact
chang
immun
respons
due
progesteron
estrogen
shown
sever
model
pregnancyrel
sex
steroid
shown
influenc
suscept
infect
listeria
monocytogen
toxoplasma
gondii
review
robert
et
al
rodent
model
higher
estrogen
level
estrogen
treatment
increas
suscept
neisseria
gonorrhoea
mycoplasma
homini
ureaplasma
urealyticum
mice
progesteron
administr
increas
mortal
infect
herp
simplex
viru
type
rat
progesteron
treatment
infect
chlamydia
trachomati
increas
suscept
uterin
infect
prevent
clearanc
organ
result
persist
infect
concurr
estrogen
treatment
limit
degre
inflammatori
respons
pregnancyrel
hormon
addit
steroid
hormon
number
placent
product
includ
corticotrophinreleas
hormon
human
chorion
gonadotropin
human
placent
lactogen
also
suppress
lymphocyt
function
activ
monocyt
prolactin
increas
pregnanc
help
suppress
cellmedi
immun
augment
b
cell
function
surviv
part
modul
cytokin
help
mediat
effect
estrogen
relationship
prolactin
level
suscept
parasit
infect
particularli
malaria
propos
diabet
mellitu
dm
pregnanc
may
preexist
either
insulindepend
noninsulin
depend
may
gestat
consequ
pregnanc
noninsulindepend
gestat
diabet
occur
greater
frequenc
nonwhit
underli
hepat
b
infect
report
risk
develop
gestat
dm
even
women
low
weight
bodi
mass
pregnanc
circul
insulin
antagonist
includ
cortisol
prolactin
human
placent
lactogen
leptin
contribut
increas
insulin
resist
worsen
preexist
diabet
medic
complic
includ
infect
frequent
pregnant
women
diabet
although
risk
occur
women
preexist
diabet
overal
fourfold
increas
risk
infect
preand
postpartum
insulindepend
diabet
pregnant
women
exampl
increas
risk
includ
colon
infect
group
b
streptococcu
postcesarean
wound
infect
unfortun
older
literatur
alway
clearli
distinguish
risk
pregnant
women
preexist
dm
risk
women
without
dm
prior
pregnanc
increas
risk
alway
extrapol
gestat
diabet
exampl
sole
gestat
dm
may
repres
increas
risk
perinat
infect
group
b
streptococcu
contrast
risk
urinari
tract
infect
particularli
due
gramposit
organ
increas
pregnant
women
preexist
gestat
dm
frequenc
urinari
tract
infect
decreas
good
glucos
control
risk
periodont
diseas
also
increas
diabet
pregnant
women
rate
gestat
diabet
even
higher
preval
women
preexist
diabet
physiolog
chang
uterin
decidu
syncytiotrophoblast
product
ido
amino
acid
tryptophan
appear
import
prolifer
signal
lymphocyt
tryptophan
metabol
enzym
indoleamin
ido
increas
ido
activ
caus
local
decreas
tryptophan
local
suppress
activ
ido
produc
tissu
macrophag
respons
dendrit
cell
respons
stimul
treg
cell
decidua
fetal
syncytiotrophoblast
pregnanc
increas
estrogen
progesteron
chorion
gonadotropin
caus
swell
endotheli
cell
pericyt
gingiv
microvasculatur
caus
gum
becom
soft
swollen
hyperem
concurr
mark
increas
proport
anaerob
speci
particularli
bacteroid
melanogenicu
prevotella
intermedia
porphyromona
gingivali
consequ
chang
pregnant
women
like
develop
gingiv
although
mechan
elucid
matern
peridont
associ
preterm
birth
low
birthweight
level
risk
correl
sever
periodont
diseas
review
krejci
anatom
chang
occur
pregnanc
associ
alter
risk
infect
promin
among
chang
urinari
tract
develop
pregnancyspecif
tissu
placenta
asymptomat
bacteriuria
occur
pregnant
nonpregn
women
pregnancyassoci
anatom
function
hormon
chang
urinari
tract
tabl
increas
infect
risk
mani
assess
risk
use
coloni
form
unit
cfu
ml
definit
bacteriuria
midstream
urin
specimen
collect
asymptomat
patient
lower
count
may
signific
patient
symptom
urin
collect
catheter
gramposit
bacteria
yeast
glucosuria
increas
urin
ph
due
bicarbon
excret
stasi
due
bladder
muscl
relax
increas
bladder
volum
encourag
bacteri
growth
urin
pregnanc
risk
cystiti
women
asymptomat
bacteriuria
coloni
count
cfuml
week
gestat
pyelonephr
common
complic
uti
due
ureter
obstruct
urinari
stasi
dilat
uret
respons
hormon
chang
increas
progesteron
possibl
estrogen
relaxin
appar
women
earli
week
gestat
hormon
factor
also
caus
decreas
ureter
peristalsi
may
progress
intermitt
atoni
later
pregnanc
addit
mechan
dilat
uret
occur
midand
late
pregnanc
due
enlarg
uteru
dilat
uret
may
contain
ml
urin
dextrorot
uteru
place
right
kidney
greater
risk
vast
major
uti
caus
escherichia
coli
although
gramposit
pathogen
increas
women
dm
treatment
asymptomat
bacteriuria
decreas
risk
subsequ
pyelonephr
respiratori
system
pregnanc
caus
progress
decreas
expiratori
reserv
volum
residu
volum
thu
function
reserv
capac
total
lung
capac
although
chang
thought
increas
risk
contract
pneumonia
decreas
respiratori
reserv
increas
risk
respiratori
failur
complic
mother
fetu
respiratori
compromis
pneumonia
decreas
matern
abil
meet
increas
oxygen
requir
need
support
fetu
addit
increas
minut
ventil
pregnanc
lead
decreas
paco
compensatori
decreas
serum
bicarbon
compens
respiratori
alkalosi
consequ
even
slight
co
retent
poorli
toler
may
contribut
increas
matern
morbid
mortal
pneumonia
particularli
third
trimest
addit
compensatori
decreas
serum
bicarbon
increas
vulner
metabol
acidosi
sepsi
caus
pneumonia
caus
viral
pathogen
particularli
varicella
influenza
measl
coronaviru
associ
sever
acut
respiratori
syndrom
sar
coccidioid
immiti
associ
sever
outcom
pregnant
women
bronchitisbronchiol
pneumonia
also
associ
higher
rate
preterm
birth
third
trimest
relax
gastroesophag
sphincter
delay
gastric
empti
increas
intraabdomin
pressur
increas
risk
aspir
aspirationrel
pneumonia
presenc
placenta
pregnancyassoci
tissu
risk
certain
infect
choriamnion
infect
associ
puerper
period
placenta
also
focu
infect
specif
organ
tropism
best
describ
plasmodium
falciparum
malaria
p
falciparum
infect
occur
pregnanc
parasit
express
specif
protein
mediat
bind
infect
erythrocyt
chondroitin
sulfat
produc
placenta
larg
number
parasit
erythrocyt
sequest
placenta
placenta
may
also
serv
nidu
infect
listeriosi
evid
guinea
pig
model
indic
infect
placenta
serv
sourc
reseed
matern
organ
mammal
l
monocytogen
infect
may
difficult
clear
placenta
expel
infect
occur
pregnanc
primarili
consequ
mother
secondarili
affect
fetu
infect
unlik
transmit
fetu
promptli
treat
increas
likelihood
advers
outcom
infant
pregnancyassoci
infect
mostli
affect
mother
occur
puerperium
period
includ
labor
follow
six
week
direct
consequ
birth
process
manag
cystiti
occur
pregnanc
although
anatom
physiolog
chang
increas
risk
urinari
tract
infect
uti
pregnant
women
major
factor
influenc
likelihood
infect
presenc
asymptomat
bacteriuria
earli
pregnanc
underli
condit
concurr
increas
risk
uti
includ
insulindepend
noninsulindepend
diabet
mellitu
acquir
immunodefici
syndrom
previou
urolog
abnorm
report
risk
factor
includ
histori
previou
uti
sickl
cell
hemoglobinopathi
earli
pregnanc
lower
socioeconom
educ
statu
previou
chlamydi
infect
illicit
drug
use
week
gestat
nonpregn
women
uti
caus
gut
flora
gener
enterobactericea
particularli
e
coli
although
gramposit
pathogen
increas
women
dm
treatment
asymptomat
bacteriuria
dramat
decreas
risk
infect
screen
women
week
gestat
urin
cultur
recommend
valu
repeat
screen
unknown
risk
uti
pyelonephr
reportedli
low
women
neg
initi
cultur
women
posit
cultur
current
recommend
treat
even
absenc
symptom
although
singl
dose
therapi
use
except
singl
dose
fosfomycin
treatment
day
effect
treatment
pregnant
women
screen
period
recurr
bacteriuria
report
sensit
leukocyt
esterasenitr
dipstick
variabl
even
larg
studi
suggest
known
high
risk
group
screen
urin
cultur
prefer
similar
regimen
followup
recommend
women
bacteriuria
also
symptom
cystiti
frequenc
urgenc
dysuria
antibiot
recommend
treatment
uti
consid
safe
use
pregnanc
list
tabl
increas
resist
treatment
modifi
base
suscept
result
unless
bacteriuria
clear
empir
therapi
women
recurr
uti
may
benefit
singl
postcoit
antibiot
dose
may
requir
daili
suppress
nitrofurantoin
cephalexin
group
b
streptococci
isol
intrapartum
penicillin
prophylaxi
requir
even
patient
screen
neg
later
date
shortterm
antibiot
therapi
unlik
advers
effect
fetu
nitrofurantoin
associ
hemolyt
anemia
defici
women
rare
pneumon
sulfonamid
may
associ
hyperbilirubinemia
unlik
signific
short
cours
treatment
acut
pyelonephr
follow
uti
asymptomat
bacteriuria
pregnant
patient
untreat
pyelonephr
like
second
third
trimest
case
occur
first
trimest
symptom
includ
fever
flank
tender
often
accompani
rigor
nausea
vomit
costovertebr
angl
pain
tender
usual
associ
pyuria
pregnant
women
pyelonephr
may
complic
preterm
labor
septic
shock
acut
respiratori
distress
syndrom
possibl
reflect
increas
sensit
endotoxin
pregnanc
pulmonari
injuri
like
occur
sicker
patient
tachycardia
high
fever
case
fluid
overload
betaagonist
given
tocolysi
recent
prospect
seri
pulmonari
insuffici
occur
pregnant
women
pyelonephr
gener
pregnant
women
pyelonephr
hospit
initi
manag
monitor
develop
complic
initi
treatment
includ
intraven
antimicrobi
care
intraven
hydrat
modif
therapi
base
cultur
result
suggest
initi
regimen
list
tabl
infect
caus
e
coli
gramposit
organ
particularli
group
b
streptococcu
increas
import
later
pregnanc
seri
caus
infect
later
pregnanc
penicillin
ampicillin
amoxicillin
use
treatment
infect
caus
group
b
streptococci
group
b
streptococci
remain
suscept
penicillin
test
need
except
case
penicillin
allergi
suscept
clindamycin
erythromycin
determin
contrast
resist
gramneg
organ
increas
particularli
ampicillin
trimethoprimsulfamethoxazol
review
urin
cultur
isol
women
age
year
collect
juli
june
hospit
center
indic
enterococc
isol
suscept
ampicillin
aureu
isol
methicillinsuscept
contrast
suscept
e
coli
ampicillin
cephalothin
tabl
suscept
isol
collect
specif
patient
obstetricsgynecolog
locat
similar
isol
women
age
year
except
enterococc
isol
ampicillinsuscept
e
coli
isol
suscept
nitrofurantoin
gfr
increas
pregnanc
dose
drug
aminoglycosid
ceftriaxon
must
adjust
accordingli
aminoglycosid
serum
drug
level
help
agent
cefazolin
requir
dose
adjust
nitrofurantoin
use
pyelonephr
limit
parenchym
penetr
afebril
oral
intak
good
diarrhea
treatment
may
chang
oral
antibiot
complet
day
cours
urin
cultur
perform
week
treatment
complet
women
improv
within
hour
initi
antibiot
treatment
evalu
possibl
obstruct
abscess
women
pyelonephr
recurr
uti
receiv
prevent
antibiot
treatment
daili
suppress
nitrofurantoin
cephalexin
postcoit
dose
week
postpartum
recommend
evid
random
control
trial
support
efficaci
adjunct
measur
increas
intak
cranberri
blueberri
product
prevent
uti
women
recurr
infect
pneumonia
pneumonia
occur
pregnanc
poorli
toler
due
increas
oxygen
requir
decreas
buffer
capac
decreas
abil
compens
acidemia
greater
affin
fetal
hemoglobin
oxygen
fetu
rel
protect
matern
oxygen
satur
becom
pao
mmhg
antibiot
mortal
pregnant
women
pneumonia
remain
third
common
caus
death
group
mortal
highest
third
trimest
streptococcu
pneumonia
varicella
zoster
common
caus
sever
pneumonia
pregnanc
except
aspir
pneumonia
third
trimest
suscept
bacteri
pneumonia
appear
increas
pregnanc
howev
medic
condit
particularli
asthma
anemia
substanti
increas
risk
bacteri
pneumonia
corticosteroid
treatment
enhanc
fetal
lung
matur
appear
increas
risk
nosocomi
pneumonia
communityacquir
pneumonia
common
bacteri
pathogen
similar
caus
diseas
nonpregn
adult
includ
pneumococcu
chlamydophila
pneumonia
mycoplasma
pneumonia
haemophilu
influenza
howev
pregnant
women
admit
bacteri
pneumonia
requir
intens
care
manag
requir
intub
mechan
ventil
frequenc
complic
bacteremia
empyema
also
increas
clinic
symptom
similar
nonpregn
women
includ
fever
cough
pleurit
chest
pain
rigor
chill
pregnant
women
possibl
diagnosi
pneumonia
undergo
chest
radiographi
admit
least
initi
observ
intraven
antibiot
applic
guidelin
american
thorac
societi
british
thorac
societi
assess
diseas
sever
pregnant
women
unknown
standard
therapi
bacteri
communityacquir
pneumonia
ceftriaxon
azithromycin
given
vancomycin
may
ad
local
decreas
pneumococc
suscept
penicillin
ceftriaxon
patient
suspect
nosocomi
pneumonia
treat
intraven
antibiot
base
resist
pattern
local
nosocomi
isol
viral
pneumonia
may
particularli
sever
pregnanc
varicella
influenza
frequent
caus
approxim
unvaccin
pregnant
women
suscept
primari
varicella
varicella
pneumonia
usual
occur
day
onset
rash
present
oral
lesion
increas
dyspnea
cough
bloodting
respiratori
secret
pleurit
chest
pain
risk
varicella
pneumonia
increas
smoker
women
underli
lung
diseas
immunosuppress
women
skin
lesion
women
infect
later
pregnanc
varicella
acquir
household
contact
chest
radiographi
demonstr
interstiti
nodular
lesion
groundglass
appear
local
infiltr
perform
women
develop
consist
symptom
although
varicella
pneumonia
occur
rate
nonpregn
adult
diseas
sever
mortal
rate
may
matern
fetal
outcom
improv
treatment
intraven
acyclovir
mgkg
everi
hour
mortal
highest
varicella
pneumonia
occur
third
trimest
known
exposur
administr
varicella
zoster
immun
globulin
vzig
within
hour
prevent
attenu
infect
varicella
infect
may
also
transmit
fetu
discuss
later
chapter
ill
due
influenza
pregnanc
increas
nonpregn
women
without
ill
risk
influenza
pneumonia
also
increas
pregnanc
pandem
mortal
rate
pregnant
women
influenza
pneumonia
although
safeti
amantidin
neuraminidas
inhibitor
unknown
pregnanc
given
sever
ill
influenza
vaccin
consid
safe
use
pregnanc
immun
recommend
prevent
ill
due
influenza
although
limit
experi
infect
due
sarscoronaviru
pregnant
women
experi
hong
kong
outbreak
suggest
fatal
rate
half
affect
women
receiv
intens
care
onethird
requir
mechan
ventil
half
women
first
trimest
spontan
fetal
loss
five
women
present
week
gestat
four
deliv
preterm
pregnancyrel
tuberculosi
increas
unit
state
develop
countri
demograph
chang
includ
increas
immigr
underli
infect
risk
acquisit
tuberculosi
immigr
commun
contrast
older
literatur
recent
studi
show
increas
risk
pregnant
women
develop
activ
tuberculosi
morbid
mortal
increas
pregnant
women
receiv
appropri
antituberculosi
treatment
howev
late
diagnosi
incomplet
treatment
associ
increas
morbid
mortal
treatment
tuberculosi
similar
pregnant
nonpregn
adult
except
streptomycin
kanamycin
amikacin
capreomycin
fluoroquinolon
use
pregnant
women
unless
treatment
option
avail
streptomycin
clearli
document
caus
congenit
deaf
pyridoxin
mg
day
supplement
requir
isoniazid
given
first
two
trimest
pregnanc
coccidioid
immiti
caus
mild
influenzalik
ill
pneumonia
third
trimest
pregnanc
risk
dissemin
increas
immunolog
hormon
chang
pregnanc
postpartum
period
thought
respons
increas
frequenc
sever
diseas
dissemin
diseas
associ
high
mortal
rate
treatment
amphotericin
b
recommend
puerper
period
spike
fever
greater
usual
caus
infect
bacteria
particularli
streptococcu
pyogen
group
betahemolyt
streptococcu
classic
caus
childb
fever
streptococcu
agalactia
group
b
betahemolyt
streptococcu
infect
group
streptococci
complic
toxic
shock
syndrom
persist
lowgrad
fever
also
suggest
bacteri
infect
postpartum
abdomin
pain
tender
fever
suggest
diagnosi
endometr
infect
decidua
myometrium
surround
tissu
bacteremia
chill
rigor
may
occur
find
foulsmel
lochia
leukocytosi
may
observ
women
without
endometr
diagnost
sever
endometr
occur
earli
within
first
hour
deliveri
lateonset
endometr
appear
week
postpartum
symptom
gener
milder
part
endometr
ascend
infect
caus
microorgan
colon
vagina
betahemolyt
streptococci
streptococci
enterococci
aureu
gramneg
enter
bacteria
e
coli
klebsiella
proteu
speci
anaerob
organ
bacteroid
prevotella
fusobacterium
clostridium
speci
chlamydia
trachomati
mycoplasma
speci
ureaplasm
urealyticum
neisseria
gonorrhoea
unit
state
endometr
rare
vagin
deliveri
risk
tripl
intervent
intern
fetal
monitor
multipl
cervic
examin
prolong
ruptur
membran
intrapartum
chorioamnion
rais
risk
durat
membran
ruptur
deliveri
increas
risk
chorioamnion
endometr
doubl
hour
hour
respect
intrapartum
chorioamnion
also
occur
preterm
women
intact
membran
organ
haemophilu
influenza
streptococcu
pneumonia
listeria
monocytogen
also
consid
cesarean
deliveri
greatest
risk
factor
endometr
prior
widespread
periop
antibiot
prophylaxi
endometr
occur
patient
administr
firstor
secondgener
cephalosporin
intraop
clamp
umbil
cord
decreas
rate
andrew
colleagu
report
addit
intraven
azithromycin
cefotetan
cefoxitin
prophylaxi
decreas
rate
poscesarean
endometr
even
highrisk
popul
benefit
azithromycin
presum
relat
activ
ureaplasma
urealyticum
mycoplasma
associ
threefold
increas
risk
endometr
endometr
occur
rare
voluntari
termin
pregnanc
prophylact
antibiot
administ
endometr
complic
suction
procedur
dilat
curettag
procedur
uterin
instil
report
endometr
medic
abort
rare
endometr
genit
tract
infect
report
fewer
women
treat
mifespriston
report
link
toxic
shock
syndrom
infect
clostridium
sordellii
clostridium
perfringen
medic
abort
appear
link
impair
local
innat
immun
due
intravagin
use
prostaglandin
misoprostol
mifespriston
endometr
suspect
pelvic
examin
perform
aerob
cultur
obtain
endocerv
canal
blood
cultur
may
posit
women
postcesarean
infect
initi
treatment
includ
coverag
anaerob
organ
addit
aerob
gramposit
gramneg
bacteria
modifi
base
cultur
result
base
metaanalysi
clinic
trial
prefer
regimen
clindamycin
mg
plu
gentamicin
mgkg
intraven
everi
hour
clindamycin
mg
plu
gentamicin
mgkg
intraven
singl
daili
dose
shown
equal
effect
fever
persist
hour
enterococc
infect
suspect
addit
ampicillin
g
intraven
everi
hour
vancomycin
recommend
patient
afebril
treatment
oral
antibiot
appear
necessari
persist
fever
discomfort
hour
may
signal
presenc
focu
requir
debrid
drainag
pelvic
abscess
infect
hematoma
presenc
pelvic
thrombophleb
computer
tomographi
pelvi
help
identifi
complic
risk
wound
infect
follow
cesarean
deliveri
rang
greatest
overweight
obes
patient
emerg
cesarean
deliveri
membran
ruptur
hour
deliveri
subcutan
hematoma
develop
risk
wound
infect
increas
ninefold
women
obes
diabet
intraop
antimicrobi
use
prevent
endometr
concurr
decreas
wound
infect
fewer
abscess
abdomin
incis
may
form
fourth
postop
day
potenti
organ
includ
may
present
amniot
fluid
time
deliveri
methicillinresist
staphylococci
nosocomi
gramneg
organ
necrot
fasciiti
rare
complic
pregnanc
larg
seri
women
undergo
cesarean
section
occur
nine
infect
polymicrobi
clearcut
risk
factor
could
identifi
necrot
fasciiti
also
occur
site
episiotomi
tear
cultur
obtain
infect
wound
necrot
tissu
must
debrid
abscess
drain
pu
sent
aerob
anaerob
cultur
antibiot
manag
includ
coverag
group
streptococci
methicillinresist
aureu
gramneg
organ
initi
treatment
abscess
necrot
fasciiti
also
requir
antianaerob
coverag
anaerob
infect
detect
patient
receiv
clindamycin
agent
broader
antianaerob
coverag
metronidazol
imipenemcilastatin
use
mastiti
infect
mammari
gland
common
occur
breast
feed
women
almost
case
appear
first
month
rare
wean
small
percentag
mastiti
complic
breast
abscess
recurr
mastiti
risk
factor
mastiti
includ
older
matern
age
fatigu
employ
outsid
home
trauma
skin
nippl
ineffect
nurs
techniqu
milk
stasi
present
symptom
chill
rigor
fever
conjunct
unilater
breast
tender
erythema
decreas
milk
product
mastiti
caus
aureu
may
transmit
mother
infant
nasal
colon
hospit
discharg
follow
streptococci
e
coli
prevent
includ
proper
posit
infant
nurs
techniqu
initi
treatment
includ
antistaphylococc
oral
antibiot
dicloxacillin
cephalothin
cultur
express
milk
obtain
fever
persist
coverag
modifi
activ
methicillinresist
aureu
women
treat
day
abscess
form
drain
ultrasoundguid
needl
aspir
surgic
prevent
puerper
infect
includ
strict
adher
infect
control
guidelin
particularli
hand
hygien
semmelweiss
describ
experi
matern
ward
vienna
hospit
demonstr
hand
disinfect
examin
pregnant
patient
dramat
decreas
mortal
childb
fever
increas
risk
endometr
associ
multipl
exam
intervent
fetal
monitor
suggest
appropri
hand
hygien
remain
essenti
measur
prevent
nosocomi
iatrogen
infect
hepat
e
viru
hev
nonenvelop
singlestrand
rna
viru
transmit
fecalor
rout
major
caus
endem
hepat
asia
middl
east
africa
central
america
like
hepat
hev
may
caus
fulmin
hepat
encephalopathi
death
howev
contrast
hepat
b
c
pregnanc
major
risk
factor
sever
infect
due
hepat
e
viru
endem
area
increas
rate
fulmin
infect
death
pregnanc
attribut
pregnancyassoci
chang
immun
function
also
direct
effect
steroid
hormon
viral
regulatori
element
control
viral
replic
studi
asian
women
acut
hev
hev
viral
load
higher
pregnant
nonpregn
women
similar
stage
diseas
sever
infect
appear
exacerb
folat
defici
commonli
complic
pregnanc
underdevelop
countri
acut
matern
infect
second
third
trimest
associ
preterm
birth
perinat
infant
death
acut
neonat
infect
hev
infant
surviv
initi
period
recov
fulli
intestin
parasitosi
biliari
ascariasi
infest
intestin
parasit
common
pregnant
women
nondevelop
world
extent
infect
type
infect
parasit
vari
accord
region
socioeconom
condit
studi
venezuela
found
women
affect
intestin
parasit
commonli
ascari
lumbricoid
trichuri
trichuria
giardia
lamblia
entamoeba
histolytica
necat
americanu
enterobiu
vermiculari
strongyloid
stercorali
pregnant
women
intestin
parasit
like
anem
anemia
may
consequ
confound
condit
rather
parasit
load
case
pregnanc
otherwis
known
alter
cours
parasit
infect
except
infect
lumbricoid
pregnanc
like
caus
biliari
ascariasi
biliari
ascariasi
may
present
acut
cholecyst
cholang
biliari
cholic
acut
pancreat
hepat
abscess
conserv
treatment
bowel
rest
antispasmod
antibiot
success
case
presenc
dead
worm
stone
strictur
may
prevent
migrat
worm
back
duodenum
necessit
surgeri
anim
model
suggest
increas
suscept
biliari
ascariasi
pregnanc
due
relax
sphincter
oddi
decreas
intestin
motil
due
smooth
muscl
dysfunct
consequ
increas
progesteron
estrogen
particularli
second
third
trimest
malari
infect
caus
increas
matern
perinat
infant
morbid
mortal
associ
matern
anemia
low
birthweight
preterm
birth
high
transmiss
area
women
partial
protect
due
previou
infect
sever
matern
anemia
low
birthweight
babi
primari
complic
low
transmiss
area
particularli
asia
latin
american
women
less
like
preexist
immun
infect
like
sever
risk
fatal
infect
higher
sever
malaria
pregnanc
caus
plasmodium
falciparum
pregnanc
even
women
endem
area
would
expect
develop
clinic
immun
malaria
develop
high
parasitemia
evid
suggest
chang
matern
spleen
function
decreas
parasit
clearanc
increas
matern
suscept
even
within
first
week
howev
major
factor
influenc
sever
malaria
pregnanc
sequestr
parasit
erythrocyt
placenta
week
pregnanc
placenta
express
chondroitin
sulfat
csa
support
clonal
expans
subpopul
parasit
express
antigen
abl
bind
csa
placenta
sequest
larg
number
parasit
erythrocyt
includ
late
trophozoit
schizont
stage
seen
peripher
blood
sequestr
occur
throughout
intervil
space
placenta
limit
vascular
wall
bind
antigen
may
occur
appear
less
import
parasit
cell
also
circul
detect
parasitemia
underestim
placent
parasit
load
examin
peripher
blood
fals
neg
risk
associ
malaria
pregnanc
greatest
first
pregnanc
sever
pregnanc
mother
develop
specif
antiadhes
antibodi
direct
malari
antigen
express
placent
variant
placent
malaria
intervil
space
contain
parasit
erythrocyt
increas
number
monocyt
macrophag
figur
phagocyt
cell
often
contain
hemozin
pigment
may
also
present
free
pigment
fibrin
deposit
may
also
contain
ingest
parasit
erythrocyt
erythrophagocytosi
figur
pigment
deposit
persist
parasit
clear
presenc
parasit
erythrocyt
hemozoin
pigment
indic
chronic
infect
placent
monocyt
macrophag
increas
chang
placent
cytokin
balanc
thought
contribut
poor
outcom
malaria
parasit
cross
placenta
infect
fetu
although
leakag
matern
cell
fetal
circul
parturit
could
potenti
lead
infect
infant
plasmodium
speci
adher
placent
receptor
infect
clinic
impact
although
chronic
infect
p
vivax
associ
matern
anemia
low
birthweight
factor
may
increas
suscept
malaria
pregnanc
includ
sustain
increas
cortisol
prolactin
level
hiv
infect
hiv
infect
decreas
respons
variantspecif
antigen
respons
bind
csa
decreas
lymphoprolif
respons
malari
antigen
impair
cytokin
respons
nonpregn
adult
level
parasitemia
invers
correl
count
malaria
endem
area
prevent
measur
includ
insecticidetr
net
prevent
mosquito
bite
intermitt
prevent
therapi
pregnanc
intermitt
treatment
least
two
dose
sulfadoxinepyramethamin
second
third
trimest
recommend
women
hiv
infect
may
requir
addit
dose
use
chloroquin
prophylaxi
longer
recommend
due
resist
current
antimalari
known
safe
treatment
first
trimest
pregnanc
quinin
proguanil
chloroquin
clindamycin
artemisininbas
combin
therapi
act
recommend
first
trimest
unless
altern
avail
recommend
malaria
treatment
pregnanc
avail
cdc
summar
tabl
schistosomiasi
common
parasit
infect
develop
world
affect
million
women
childbear
age
mostli
subsaharan
africa
haematobium
mansonii
western
pacif
japonicum
contrast
infect
malaria
pregnancyrel
chang
immun
parasitespecif
antigen
express
seem
factor
cours
diseas
howev
schistosomiasi
advers
affect
pregnanc
outcom
low
birthweight
japonicum
preterm
deliveri
haematobium
potenti
pathogen
mechan
includ
matern
iron
defici
anemia
due
direct
blood
loss
stool
mansonii
japonicum
urin
haematobium
associ
chronic
diseas
inflamm
respons
placent
infect
immatur
worm
egg
consequ
cytokin
product
haematobium
infect
stimul
cytokin
product
follow
bind
circul
antigen
placent
tlr
propos
similar
outcom
shown
anim
model
experiment
infect
rat
mansonii
infect
rat
fewer
pregnanc
fewer
surviv
pup
higher
matern
death
rate
higher
spontan
abort
rate
lower
pup
weight
birth
earli
infanc
analog
find
obtain
infect
pig
congenit
transmiss
also
describ
consid
pregnant
women
schistosomiasi
highrisk
recommend
treatment
treat
earli
diseas
cours
hepat
gastrointestin
urinari
tract
patholog
revers
praziquantel
list
pregnanc
class
b
agent
advers
effect
report
year
postmarket
monitor
infect
pregnanc
mother
minim
affect
transmiss
fetu
major
concern
consequ
fetal
infect
devast
mani
infect
growth
fetu
may
affect
intrauterin
growth
retard
infant
may
deliv
prematur
miscarriag
preterm
birth
even
absenc
congenit
infect
toxoplasmosi
zoonot
parasit
infect
caus
infect
toxoplasma
gondii
cat
definit
host
parasit
human
intermedi
host
infect
cat
exposur
ingest
raw
undercook
meat
infect
water
contamin
soil
cat
less
like
infect
asia
risk
direct
cat
exposur
less
like
unit
state
europ
congenit
toxoplasmosi
usual
occur
associ
primari
infect
pregnanc
although
congenit
transmiss
report
chronic
infect
mother
even
absenc
immunocompromis
gondii
activ
invad
cell
cross
biolog
barrier
includ
placenta
bloodbrain
barrier
congenit
toxoplasmosi
caus
dissemin
infect
fetu
gondii
dna
detect
amniot
fluid
blood
cerebrospin
fluid
fetal
tissu
incub
period
toxoplasmosi
day
case
asymptomat
mother
present
local
lymphadenopathi
symptom
mononucleosi
evalu
possibl
congenit
toxoplasmosi
includ
matern
serolog
molecular
amplif
test
gondii
dna
amniot
fluid
matern
igm
antibodi
appear
within
week
infect
follow
iga
ige
igm
respons
peak
month
gener
wane
month
igg
respons
peak
month
author
suggest
pregnant
seroconvert
test
iga
ige
level
bind
avid
igg
iga
ige
may
help
sinc
avid
increas
infect
low
avid
suggest
recent
infect
congenit
infect
treat
birth
best
outcom
report
treatment
initi
within
week
seroconvers
treatment
includ
sulfadiazin
plu
pyramethamin
birth
clindamycin
use
earli
pregnanc
risk
primari
toxoplasmosi
pregnanc
minim
avoid
consumpt
raw
undercook
meat
wash
hand
utensil
thoroughli
contact
raw
meat
wash
uncook
veget
wear
glove
contact
soil
wash
hand
thoroughli
immedi
thereaft
cat
kept
indoor
pregnant
women
chang
cat
litter
wash
hand
immedi
contact
cat
rubella
rubella
german
measl
gener
mild
childhood
ill
caus
devast
congenit
infect
infant
nonimmun
mother
particularli
infect
acquir
first
trimest
avail
vaccin
number
rubella
case
declin
unit
state
characterist
epidem
cycl
rubella
longer
evid
congenit
transmiss
elimin
unit
state
sinc
substanti
progress
toward
elimin
western
hemispher
worldwid
made
due
aggress
vaccin
program
rubella
viru
transmit
respiratori
tract
aerosol
enter
suscept
host
nasopharyng
epithelium
viru
transport
via
blood
lymph
node
spleen
replic
reticuloendotheli
cell
six
day
initi
infect
viru
reenter
blood
dissemin
wide
rash
appear
shortli
thereaft
viru
shed
nasopharynx
begin
day
exposur
day
onset
rash
account
extend
period
infect
younger
children
rubella
mild
ill
caus
lowgrad
fever
last
less
hour
maculopapular
rash
face
neck
last
day
malais
mani
children
complet
asymptomat
although
rare
case
rubella
enceph
report
older
children
adolesc
adult
rubella
symptom
may
includ
sever
day
fever
headach
malais
coryza
conjunct
ill
may
complic
cervic
adenopathi
preced
rash
sever
day
arthralgia
arthriti
occur
older
girl
women
thrombocytopen
purpura
may
also
occur
rare
pregnanc
rubella
infect
transmit
transplacent
caus
dissemin
infect
result
miscarriag
stillbirth
damag
variou
fetal
organ
congenit
rubella
syndrom
rubella
infect
caus
cell
death
inhibit
mitosi
vascular
endotheli
damag
impact
greatest
organogenesi
infect
occur
first
trimest
pregnanc
fetus
affect
percentag
affect
infant
declin
progress
second
trimest
classic
find
congenit
rubella
includ
cataractscongenit
glaucoma
congenit
heart
diseas
commonli
patent
ductu
arteriosu
peripher
pulmonari
arteri
stenosi
hear
impair
pigmentari
retinopathi
organ
system
affect
congenit
rubella
infect
also
caus
enceph
mental
retard
pneumonia
hepat
thrombocytopenia
growth
plate
defect
diabet
mellitu
thyroid
congenit
infect
babi
excret
rubella
viru
birth
month
highli
infecti
rubella
vaccineprevent
ill
live
attenu
rubella
viru
vaccin
avail
use
year
current
two
dose
combin
measlesmumpsrubella
mmr
vaccin
recommend
current
schedul
children
adolesc
suscept
women
childbear
age
vaccin
although
extens
postvaccin
surveil
turn
instanc
congenit
rubella
follow
inadvert
vaccin
administr
pregnant
women
current
recommend
women
known
pregnant
vaccin
concept
avoid
day
receipt
rubellacontain
vaccin
adult
women
develop
acut
transient
arthralgia
arthriti
vaccin
evid
support
associ
chronic
joint
problem
subclin
thrombocytopenia
may
observ
vaccin
infect
human
cytomegaloviru
hcmv
common
congenit
viral
infect
affect
least
liveborn
infant
develop
countri
sever
fetal
infect
occur
primari
matern
infect
congenit
transmiss
rate
infant
symptomat
birth
addit
develop
late
neurolog
find
primari
cmv
infect
third
trimest
highest
rate
congenit
transmiss
earli
pregnanc
spontan
abort
occur
often
accompani
evid
placent
infect
even
without
sign
fetal
infect
congenit
infect
also
follow
reactiv
endogen
matern
cmv
infect
mother
reinfect
new
strain
lower
rate
presum
partial
matern
immun
risk
congenit
infect
nonprimari
infect
previous
estim
recent
prospect
studi
found
much
higher
rate
almost
recogn
congenit
infect
infant
mother
previou
immun
cmv
evid
secondari
infect
pregnanc
infant
asymptomat
birth
risk
late
neurolog
diseas
hcmv
infect
mani
cell
type
includ
fibroblast
epitheli
endotheli
cell
macrophag
muscl
cell
latenc
establish
primari
infect
control
consequ
congenit
hcmv
may
caus
symptom
virtual
organ
system
commonli
central
nervou
system
liver
spleen
gastrointestin
tract
hematopoiet
system
diseas
may
mild
fulmin
infant
mortal
rate
find
typic
congenit
hcmv
infect
includ
intrauterin
growth
retard
jaundic
hepatospenomegali
enter
pneumon
respiratori
distress
rash
chorioretin
pancytopenia
central
nervou
system
find
meningoenceph
calcif
microcephali
ventriculomegali
ocular
abnorm
cerebellar
hypoplasia
relat
symptom
includ
lethargi
seizur
cognit
motor
deficit
hear
loss
affect
infant
find
hcmv
birth
infant
appear
asymptomat
deficit
mental
retard
visual
motor
impair
less
common
infant
asymptomat
birth
primari
matern
hcmv
infect
matern
viremia
lead
placent
infect
subsequ
hematogen
dissemin
fetu
matern
leukocyt
transmit
infect
either
migrat
later
pregnanc
direct
contact
fetal
endothelium
indirectli
contact
uterin
endotheli
cell
contact
cell
cytotrophoblast
case
congenit
transmiss
mother
recurr
cmv
local
immunosuppress
uteru
thought
allow
hcmv
reactiv
uterin
macrophag
infect
invad
cytotrophoblast
cell
allow
viral
spread
fetu
infect
fetu
hcmv
detect
blood
viremia
persist
month
birth
congenit
hcmv
consid
mother
develop
primari
secondari
cmv
infect
primari
matern
hcmv
infect
document
posit
viral
cultur
molecular
test
seroconvers
suggest
igm
antibodi
remain
posit
month
thu
may
reflect
acut
infect
secondari
infect
suggest
signific
increas
igg
titer
presenc
igm
igm
assay
give
falseposit
result
routin
serolog
screen
recommend
pregnanc
absenc
matern
symptom
find
ultrasonographi
newborn
infant
diagnosi
congenit
infect
made
detect
viru
sputum
urin
larg
amount
viru
shed
cultur
nearli
sensit
specif
set
molecular
method
need
howev
antenat
diagnosi
difficult
fetal
blood
sampl
cmvspecif
igm
antibodi
longer
recommend
risk
associ
cordocentesi
specif
anticmv
igm
may
develop
late
pregnanc
assay
amniot
fluid
viru
prefer
amniot
fluid
detect
hcmv
convent
shell
vial
cultur
method
gold
standard
prenat
diagnosi
molecular
detect
sensit
vs
amniot
fluid
cultur
still
highli
specif
detect
even
small
amount
hcmv
dna
correl
congenit
infect
birth
import
quantit
hcmv
dna
test
less
clear
sinc
level
correl
structur
abnorm
ultrasound
symptomat
versu
asymptomat
infect
birth
studi
amniot
fluid
test
viru
cultur
assay
viral
dna
immediateearli
mrna
late
express
mrna
obtain
posit
result
two
assay
posit
predict
valu
congenit
infect
convers
inabl
detect
hcmv
two
assay
neg
predict
valu
unfortun
antenat
test
procedur
limit
risk
falseneg
result
perform
earli
sensit
prenat
diagnosi
increas
week
respect
elaps
matern
infect
test
least
week
requir
fetal
infect
viral
dissemin
follow
viral
replic
kidney
excret
viru
amniot
fluid
via
fetal
urin
thu
test
consid
reliabl
week
gestat
less
week
matern
infect
contamin
matern
blood
tissu
also
occur
lead
falseposit
result
limit
recommend
limit
prenat
diagnosi
mother
known
highli
suspect
primari
hcmv
infect
andor
presenc
fetal
ultrasonograph
abnorm
fdaapprov
antivir
agent
treatment
congenit
cmv
infect
treatment
symptomat
infant
diagnos
birth
intraven
ganciclovir
mgkg
everi
hour
week
benefit
infant
pneumonia
prevent
hear
loss
efficaci
antenat
ganciclovir
prevent
sequela
due
congenit
hcmv
infect
conclus
demonstr
prospect
clinic
trial
perform
itali
treatment
pregnant
women
confirm
primari
cmv
cmvspecif
immun
globulin
decreas
rate
symptomat
congenit
infect
birth
contrast
untreat
group
hcmv
may
also
transmit
birth
via
breast
milk
postnat
acquir
hcmv
appear
associ
neurolog
cognit
abnorm
increas
morbid
except
case
coincid
congenit
hiv
infect
transmiss
hcmv
occur
contact
blood
bodi
secret
saliva
urin
fece
semen
vagin
secret
breast
milk
tear
infect
person
risk
reduct
includ
limit
potenti
exposur
practic
monogami
avoid
contact
saliva
urin
particularli
toddler
young
children
follow
handwash
gener
good
hygien
practic
hsv
infect
sever
pregnanc
recurr
frequent
sever
last
longer
primari
infect
may
lead
sever
ill
matern
mortal
rate
dissemin
infect
occur
seroposit
high
gener
popul
small
number
women
true
primari
hsv
infect
pregnanc
sever
primari
diseas
like
women
develop
gingivostomat
vulvovagin
particularli
infect
occur
third
trimest
associ
dissemin
skin
lesion
evid
multiorgan
involv
includ
hepat
enceph
matern
hsv
infect
also
associ
congenit
infect
affect
newborn
matern
antibodi
protect
influenc
rate
transmiss
decreas
primari
matern
infect
nonprimari
first
episod
infect
woman
serolog
evid
previou
infect
type
recurr
hsv
infect
intrauterin
infect
account
congenit
hsv
infect
greatest
risk
intrauterin
hsv
transmiss
occur
primari
dissemin
matern
infect
first
week
pregnanc
intrauterin
infect
also
report
associ
recurr
matern
infect
period
intrauterin
infect
may
consequ
either
viremia
ascend
infect
intrauterin
infect
caus
sever
factor
may
contributori
includ
greater
background
seroposit
smaller
likelihood
recurr
infect
due
greater
resist
infect
placent
syncytiotrophoblast
cell
lack
receptor
entri
intrauterin
infect
risk
includ
pregnanc
loss
congenit
malform
classic
infant
intrauterin
hsv
infect
develop
sever
skin
vesicl
scar
eye
microphthalmia
chorioretin
cataract
brain
microcephali
hydrocephali
intracrani
calcif
encepahlomalacia
seizur
lesion
limb
hypoplasia
similar
seen
congenit
varicella
syndrom
also
report
transmiss
time
deliveri
account
major
congenit
hsv
infect
infant
commonli
infect
hsv
contact
matern
lesion
passag
birth
canal
transmiss
avoid
treatment
women
recurr
hsv
acyclovir
term
cesarean
deliveri
lesion
present
cesarean
deliveri
reduc
risk
neonat
hsv
although
lesion
almost
alway
pain
primari
infect
symptom
usual
less
sever
recurr
infect
patient
may
even
asymptomat
particularli
lesion
limit
cervix
vagina
thu
care
examin
extern
genitalia
cervix
must
perform
mother
enter
labor
neonat
may
infect
skin
eye
mouth
seriou
cn
dissemin
infect
associ
infant
mortal
respect
residu
neurolog
impair
typespecif
serolog
test
earli
pregnanc
use
determin
suscept
infect
risk
recurr
greater
infect
help
distinguish
primari
vs
recurr
infect
associ
risk
congenit
transmiss
women
becom
symptomat
later
pregnanc
primari
recurr
infect
diagnosi
confirm
rapidli
direct
fluoresc
antibodi
test
shell
vial
convent
viral
cultur
materi
matern
lesion
molecular
method
pcr
hsv
dna
gener
requir
lesion
present
hsv
infect
pregnant
women
treat
way
nonpregn
women
caveat
antivir
agent
acyclovir
use
often
appear
associ
teratogen
effect
regimen
includ
acyclovir
mg
oral
three
time
per
day
acyclovir
mg
oral
time
per
day
day
primari
infect
day
recurr
infect
suppress
hsv
recurr
acyclovir
mg
oral
three
time
per
day
begin
week
pregnanc
shown
reduc
recurr
around
time
deliveri
need
cesarean
section
valacyclovir
also
appear
safe
pregnanc
use
less
extens
best
measur
reduc
congenit
hsv
infect
prevent
transmiss
mother
step
prevent
primari
infect
mother
infect
new
hsv
strain
hsvinfect
contact
includ
minim
exposur
avoid
intercours
outbreak
use
condom
avoid
orolabi
contact
antivir
treatment
hsvinfect
partner
parvoviru
caus
childhood
ill
erythema
infectiosum
fifth
diseas
adult
particularli
women
infect
associ
acut
sometim
persist
symmetr
arthriti
wrist
ankl
knee
patient
underli
diseas
may
develop
sever
symptom
transient
aplast
crisi
patient
sickl
cell
anemia
refractori
anemia
thrombocytopenia
immunocompromis
individu
infect
second
trimest
pregnanc
caus
fetal
anemia
hydrop
death
even
matern
infect
mild
asymptomat
immun
parvoviru
base
primarili
neutral
antibodi
pregnanc
appear
affect
suscept
infect
cours
diseas
mother
data
unit
state
europ
indic
one
half
women
suscept
time
pregnanc
endem
period
epidem
previous
seroneg
women
childbear
age
infect
parvoviru
annual
viremia
develop
day
exposur
parvoviru
may
produc
symptom
headach
fever
malais
coryza
may
asymptomat
individu
infect
bone
marrow
erythrocyt
progenitor
cell
precursor
erythroblast
megakaryocyt
caus
format
giant
pronormoblast
cytoplasm
vacuol
larg
eosinophil
nuclear
inclus
bodi
follow
cell
death
acut
drop
peripher
reticulocyt
caus
anemia
leukopenia
thrombocytopenia
may
also
occur
pathogen
effect
infect
cell
matur
erythrocyt
synovium
placenta
fetal
myocardium
endothelium
less
clear
transmiss
fetu
occur
onethird
matern
infect
infect
occur
week
period
hepat
hematopoiesi
fetu
develop
sever
fetal
anemia
lead
high
output
cardiac
failur
nonimmun
hydrop
short
lifespan
fetal
erythrocyt
threeto
fourfold
increas
erythrocyt
need
accommod
fetal
growth
period
estim
retrospect
case
seri
place
overal
risk
fetal
hydrop
follow
parvoviru
infect
much
infect
occur
week
gestat
age
death
hydrop
occur
untreat
case
within
week
matern
infect
treatment
includ
intrauterin
transfus
improv
surviv
case
sever
hydrop
earli
studi
suggest
overal
outcom
matern
parvoviru
infect
good
liveborn
infant
growth
gener
health
normal
howev
recent
followup
studi
infant
treat
transfus
hydrop
surviv
children
development
delay
attribut
etiolog
parvoviru
bind
suscept
cell
globosid
pantigen
individu
lack
pantigen
infect
viru
howev
pantigen
express
suffici
viral
entri
cell
requir
presenc
function
coreceptor
integrin
possibl
placent
express
pantigen
highest
earli
pregnanc
gradual
declin
becom
undetect
third
trimest
may
influenc
likelihood
maternalfet
transmiss
viral
encod
phosphoprotein
control
viral
transcript
replic
caus
host
cell
death
direct
toxic
promot
cell
cycl
arrest
apoptosi
protein
also
caus
releas
placent
proinflammatori
cytokin
associ
poor
pregnanc
outcom
immunocompet
subject
virusspecif
igm
appear
within
day
symptom
day
exposur
control
viremia
specif
igg
appear
within
day
associ
immun
complex
format
develop
arthropathi
characterist
laci
red
slap
cheek
rash
recoveri
reticulocyt
resolut
anemia
diagnosi
matern
parvoviru
infect
primarili
base
serolog
virusspecif
igm
persist
month
commerci
avail
assay
sensit
specif
molecular
method
realtim
pcr
parvoviru
dna
situ
hybrid
use
evalu
fetal
matern
specimen
sinc
viral
dna
persist
asymptomat
individu
parvoviru
cultur
routin
method
matern
infect
diagnos
fetu
monitor
weekli
ultrasonographi
week
increas
peak
systol
flow
veloc
middl
cerebr
arteri
sensit
marker
fetal
anemia
develop
hydrop
manifest
combin
gener
edema
subcutan
edema
ascit
pleural
effus
pericardi
effus
placent
edema
polyhydramnio
optim
stage
intervent
fetal
transfus
establish
recent
third
trimest
fetal
loss
absenc
fetal
hydrop
associ
parvoviru
dna
placent
tissu
report
fetal
loss
occur
often
week
could
occur
week
infect
case
matern
infect
asymptomat
serolog
respons
delay
absent
caus
death
infant
clear
autopsi
parvoviru
infect
occur
winter
spring
epidem
year
interv
respiratori
secret
infect
person
contagi
immunocompet
secret
infecti
appear
rash
arthropathi
immunocompromis
individu
unabl
make
antibodi
clear
viru
infecti
extend
period
hand
respiratori
hygien
recommend
prevent
except
healthcar
set
isol
restrict
activ
recommend
cdc
sinc
diagnosi
usual
made
characterist
rash
appear
individu
longer
infecti
pregnant
women
acquir
infect
famili
set
parvoviru
small
nonenvelop
singlestrand
dna
viru
stabl
current
blood
decontamin
method
also
transmit
contamin
blood
product
recombin
vaccin
medimmun
capsid
protein
evalu
benefit
intraven
immunoglobulin
prophylaxi
exposur
systemat
evalu
recent
describ
member
parvovirida
found
human
specimen
includ
three
erythroviru
strain
close
relat
two
novel
parvovirus
human
bocaviru
limit
inform
avail
role
strain
clinic
diseas
describ
earlier
chapter
chickenpox
varicella
zoster
viru
vzv
pregnanc
associ
sever
cours
diseas
varicella
pneumonia
present
risk
matern
ventilatori
failur
associ
high
mortal
also
risk
develop
fetu
usual
consequ
matern
viremia
infect
occur
first
week
pregnanc
congenit
varicella
develop
almost
manifest
dermatom
skin
lesion
cicatrici
scar
skin
loss
low
birthweight
eye
microphthalmia
enophthalmia
chorioretin
cataract
nystagmu
anisocoria
optic
atrophi
brain
lesion
cortic
atrophi
spinal
cord
atrophi
limb
paresi
microcephali
seizur
horner
syndrom
enceph
dysphagia
skelet
anomali
limb
hypoplasia
almost
onethird
infant
congenit
varicella
die
within
month
fetu
unabl
mount
cellmedi
immunerespons
vzv
infect
zosterlik
reactiv
associ
enceph
thought
caus
typic
lesion
congenit
varicella
neonat
varicella
occur
infant
whose
mother
infect
week
prior
deliveri
infant
infect
week
prior
deliveri
develop
chickenpox
gener
well
sinc
matern
igg
develop
transfer
infant
infant
mother
infect
closer
deliveri
matern
rash
day
prior
deliveri
acquir
matern
antibodi
infant
chanc
develop
fulmin
dissemin
infect
risk
death
infect
vzv
occur
due
transplacent
infect
follow
matern
viremia
ascend
infect
birth
respiratori
infect
birth
matern
shingl
appear
associ
risk
congenit
infect
matern
antibodi
appear
protect
diagnosi
matern
varicella
gener
made
clinic
confirm
rapidli
direct
fluoresc
antibodi
test
shell
vial
convent
viral
cultur
materi
matern
lesion
serolog
cultur
less
reliabl
congenit
varicella
molecular
method
pcr
viral
dna
may
need
differenti
coxsacki
b
viru
may
present
similarli
amniot
fluid
test
antenat
limit
case
fetal
ultrasound
examin
demonstr
find
consist
diagnosi
sinc
posit
amniot
fluid
result
may
obtain
absenc
fetal
malform
activ
immun
women
pregnanc
recommend
sinc
varicella
vaccin
contain
live
although
attenu
viru
women
wait
least
week
vaccin
becom
pregnant
vaccin
given
women
alreadi
pregnant
expos
suscept
pregnant
women
receiv
varicella
zoster
immun
globulin
vzig
kg
maximum
u
intramuscularli
within
hour
littl
inform
avail
use
acyclovir
prophylaxi
matern
exposur
prevent
congenit
varicella
syndrom
may
benefit
higher
dose
acyclovir
mg
oral
five
time
per
day
requir
time
also
appear
issu
treatment
day
exposur
recommend
mani
women
continu
intercours
even
late
pregnanc
thu
continu
risk
acquir
sti
data
cdc
indic
new
sti
women
childbear
age
occur
pregnanc
sti
discuss
elsewher
volum
discuss
focus
primarili
impact
sti
pregnanc
congenit
infect
screen
treatment
guidelin
establish
cdc
american
colleg
obstetrician
gynecologist
chlamydia
infect
chlamydia
trachomati
ct
may
commonli
diagnos
bacteri
sti
pregnanc
ct
frequent
caus
cervic
endometr
salping
periton
reactiv
arthriti
reiter
syndrom
infertil
associ
pelvic
infect
epidemiolog
data
suggest
women
previou
pelvic
infect
whether
symptomat
asymptomat
risk
ectop
pregnanc
ct
transmit
infant
passag
birth
canal
infect
women
neonat
ct
caus
conjunct
pharyng
pneumonia
genit
tract
infect
ct
conjunct
prevent
neonat
prophylaxi
requir
prolong
treatment
prevent
blind
pregnant
women
test
first
prenat
visit
posit
treat
retest
week
later
women
less
year
increas
risk
new
partner
multipl
partner
previou
std
area
high
preval
retest
third
trimest
women
screen
use
nucleic
acid
amplif
test
urin
vagin
cervic
specimen
direct
fluoresc
antibodi
test
cultur
recommend
rectal
specimen
although
nucleic
acid
amplif
test
sensit
valid
laboratori
treatment
azithromycin
g
oral
singl
dose
prefer
doxycyclin
administ
pregnanc
pregnant
women
neisseria
gonorrhoea
infect
may
local
infect
cervic
urethr
pharyng
proctiti
also
appear
somewhat
increas
risk
dissemin
infect
matern
infect
associ
threefold
increas
risk
preterm
birth
matern
genit
infect
may
result
neonat
gonococc
conjunct
pharyng
neonat
sepsi
dissemin
infect
risk
blind
infant
develop
conjunct
due
gonococc
infect
silver
nitrat
antibiot
ointment
routin
administ
ophthalm
prophylaxi
screen
first
third
trimest
recommend
women
high
risk
infect
new
partner
multipl
partner
previou
sti
area
high
preval
gonococc
infect
pregnant
women
diagnosi
nucleic
amplif
method
prefer
although
cultur
use
rectal
pharyng
specimen
prefer
treatment
local
infect
ceftriaxon
mg
intramuscularli
cefixim
mg
oral
singl
dose
azithromycin
g
oral
may
use
case
cephalosporin
allergi
dissemin
infect
requir
higher
dose
prolong
treat
depend
site
infect
diagnosi
infect
infant
gener
use
cultur
method
pregnanc
alter
clinic
cours
syphili
pregnant
women
high
risk
transmiss
syphili
fetu
stage
syphili
risk
greatest
primari
secondari
syphili
remain
high
earli
latent
infect
latent
matern
infect
year
durat
risk
transmiss
becom
minim
women
infect
period
longer
year
syphili
caus
spontan
abort
preterm
birth
congenit
malform
longterm
neurolog
deficit
fetal
abnorm
appear
consequ
immun
respons
treponem
organ
convers
due
limit
fetal
inflammatori
respons
sign
clinic
diseas
fetu
week
gestat
consequ
sequela
treatment
institut
promptli
diseas
detect
earli
pregnanc
syphili
dissemin
infect
untreat
infect
fetu
week
gestat
lead
multiorgan
diseas
hepat
involv
occur
earli
associ
decreas
fetal
erythrocyt
product
anemia
follow
output
failur
ascit
hydrop
sometim
death
infant
viabl
birth
may
jaundic
petechia
purpura
diffus
adenopathi
rhiniti
snuffl
pneumonia
myocard
nephrosi
syphilit
infect
also
alter
placent
function
due
chang
villi
becom
thicken
clubshap
evid
vascular
insuffici
due
endarter
stromal
prolifer
pregnant
women
screen
syphili
treponem
nontreponem
serolog
test
first
prenat
visit
prefer
deliveri
women
high
risk
also
screen
week
gestat
women
treat
benzathin
penicillin
million
unit
intramuscularli
singl
dose
earli
syphili
weekli
dose
week
syphili
greater
year
durat
penicillinallerg
women
desensit
nontreponem
test
repeat
week
gestat
deliveri
month
treatment
primari
secondari
syphili
month
treatment
late
latent
syphili
bacteri
vaginosi
bv
trichomona
vaginali
tv
infect
occur
almost
exclus
sexual
activ
women
sexual
transmiss
establish
bv
singl
agent
appear
respons
develop
syndrom
although
multipl
bacteri
speci
evalu
bv
tv
infect
caus
increas
vagin
secret
often
unpleas
odor
women
may
complain
itch
dysuria
asymptomat
pregnanc
bv
tv
infect
associ
increas
risk
preterm
birth
screen
bv
first
prenat
visit
recommend
asymptomat
pregnant
women
histori
preterm
birth
diagnosi
base
clinic
find
presenc
clue
cell
wet
mount
treatment
either
metronidazol
mg
oral
twice
daili
mg
oral
three
time
daili
clindamycin
mg
oral
twice
daili
may
given
total
day
routin
screen
asymptomat
women
without
histori
prior
preterm
birth
recommend
prospect
trial
yield
conflict
result
regard
benefit
treatment
asymptomat
women
prevent
preterm
birth
metaanalysi
trial
three
includ
women
consid
high
risk
previou
preterm
birth
suggest
signific
effect
antibiot
treatment
preterm
birth
routin
screen
tv
infect
current
recommend
genit
wart
may
prolifer
grow
larger
friabl
pregnanc
may
progress
neoplasm
larg
lesion
may
interfer
deliveri
addit
human
papilloma
viru
hpv
type
caus
respiratori
papillomatosi
infant
children
unknown
whether
infect
transmit
transplacent
perinat
cesarean
deliveri
recommend
prevent
transmiss
imiqiumod
podophyllin
podophyllotoxin
use
pregnanc
treatment
need
lesion
treat
cryotherapi
trichloracet
acid
surgeri
cdc
recommend
women
screen
hiv
infect
earli
pregnanc
week
high
isk
unless
test
declin
optout
approach
univers
test
recommend
sinc
studi
found
onethird
women
whose
hiv
infect
first
detect
pregnanc
awar
report
risk
factor
hiv
infect
test
rapid
hiv
test
recommend
women
whose
hiv
statu
unknown
time
labor
onset
recommend
optim
manag
hivinfect
pregnant
women
updat
regularli
recent
public
health
servic
recommend
plu
avail
data
regard
safeti
variou
antiretrovir
pregnanc
manag
suggest
variou
common
clinic
scenario
avail
wwwaidsinfo
nihgov
recommend
summar
tabl
guidelin
primarili
address
prevent
transmiss
littl
inform
avail
regard
manag
mother
goal
hiv
manag
pregnanc
maxim
health
mother
prevent
maternalfet
transmiss
hiv
initi
evalu
hivinfect
pregnant
woman
includ
assess
immun
function
need
prophylaxi
opportunist
infect
treatment
pregnant
women
complic
need
avoid
drug
teratogen
potenti
particularli
first
trimest
efavirenz
particular
associ
central
nervou
system
defect
anim
studi
case
report
altern
agent
substitut
whenev
possibl
even
women
alreadi
take
regimen
includ
howev
haart
offer
hivposit
women
sinc
antiretrovir
therapi
shown
reduc
congenit
hiv
transmiss
even
mother
viral
load
less
copiesml
whenev
possibl
women
expos
haart
pregnanc
enter
antiretrovir
pregnanc
registri
wwwapregistrycom
infant
untreat
mother
risk
congenit
hiv
transmiss
hiv
transmiss
minim
administr
haart
combin
intrapartum
postpartum
zidovudin
intrapartum
prophylaxi
alon
suffici
although
transmiss
occur
intrapartum
estim
occur
period
prior
deliveri
week
period
week
gestat
account
signific
proport
transmiss
risk
peripartum
transmiss
increas
preterm
birth
prolong
ruptur
membran
elect
cesarean
deliveri
may
reduc
risk
hiv
transmiss
much
associ
increas
risk
matern
complic
includ
endometr
sepsi
pneumonia
cesarean
deliveri
primarili
recommend
women
persist
elev
viral
load
whose
viral
load
unknown
addit
reduc
risk
hiv
transmiss
infant
antiretrovir
therapi
mother
reduc
risk
infant
death
combin
antiretrovir
therapi
current
standard
care
although
number
regimen
includ
zidovudin
azt
alon
azt
plu
lamivudin
nevirapin
alon
variou
durat
pregnanc
labor
infant
birth
demonstr
least
partial
efficaci
combin
therapi
includ
proteas
inhibitor
decreas
congenit
hiv
transmiss
comparison
infant
untreat
women
regimen
gener
includ
azt
sinc
passag
across
placenta
excel
dose
recommend
azt
given
tabl
haart
prophylaxi
start
week
gestat
l
monitor
women
proteas
inhibitor
glucos
intoler
l
fetal
ultrasound
first
trimest
confirm
gestat
age
l
intraven
zidovudin
given
labor
even
women
evid
resist
genotyp
l
schedul
cesarean
deliveri
hiv
rna
copiesml
near
deliveri
l
avoid
artifici
ruptur
membran
invas
monitor
forcep
vacuum
extractor
deliveri
l
avoid
methergin
ergot
women
receiv
proteas
inhibitor
efavirenz
l
week
zidovudin
prophylaxi
infant
dose
gestat
age
consid
addit
agent
high
matern
viral
load
resist
start
within
hour
birth
l
woman
breastfe
women
alreadi
receiv
antiretrovir
therapi
resist
test
recommend
therapi
initi
women
whose
viral
load
remain
elev
antiretrovir
avoid
pregnanc
includ
efavirenz
teratogen
nevirapin
hepat
dysfunct
women
cellsmm
stavudin
plu
didanosin
lactic
acidosi
pregnant
women
receiv
proteas
inhibitor
may
requir
increas
dose
third
trimest
earli
intrauterin
infect
hiv
associ
intrauterin
growth
retard
microcephali
craniofaci
abnorm
sever
cohort
studi
infant
hivinfect
mother
shown
increas
morbid
mortal
whether
infect
hiv
although
risk
highest
infant
infect
birth
within
first
week
life
matern
morbid
mortal
absolut
cell
count
cellsmm
increas
matern
viral
load
predictor
infant
morbid
mortal
infant
often
present
pneumonia
sepsi
breastfeed
contribut
transmiss
infant
hivposit
mother
advis
breastfe
even
receiv
haart
hivposit
women
chronic
hepat
b
coinfect
may
benefit
regimen
includ
tenofovir
plu
emtricitabin
ftc
women
must
monitor
hepat
toxic
antiretrovir
therapi
discontinu
postpartum
risk
hepat
flare
hepat
hav
common
infect
caus
small
nonenvelop
rna
viru
easili
spread
fecalor
rout
incub
period
day
initi
symptom
flulik
fever
myalgia
headach
follow
elev
serum
hepat
transaminas
jaundic
fulmin
infect
may
accompani
coagulopathi
sign
acut
liver
failur
hav
infect
rare
pregnanc
develop
countri
occur
find
retrospect
studi
suggest
risk
preterm
labor
pregnanc
complic
increas
acut
matern
hav
infect
occur
second
third
trimest
hav
infect
diagnos
detect
antihav
igm
serum
therapi
support
bed
rest
iv
fluid
antiemet
vitamin
k
coagulopathi
perinat
transmiss
occur
travel
birth
canal
prevent
hav
infect
includ
administr
inactiv
vaccin
safe
pregnanc
women
travel
high
risk
intramuscular
immunoglobulin
known
exposur
occur
hepat
b
viru
hbv
doubl
strand
dna
viru
replic
use
revers
transcript
step
transmiss
occur
contact
blood
bodi
fluid
sexual
transmiss
wellrecogn
incub
l
mgkg
bodi
weight
per
dose
given
oral
l
mgkg
bodi
weight
per
dose
given
intraven
begun
within
hour
sooner
birth
given
everi
hour
l
begin
birth
treat
age
week
week
week
l
mgkg
bodi
weight
per
dose
given
oral
l
mgkg
bodi
weight
per
dose
given
intraven
begun
within
hour
sooner
birth
given
everi
hour
increas
everi
hour
age
week
l
begin
birth
treat
age
week
week
l
mg
per
kg
bodi
weight
per
dose
given
oral
l
mg
per
kg
bodi
weight
per
dose
given
intraven
begun
within
hour
sooner
birth
given
everi
hour
increas
everi
hour
age
week
l
begin
birth
treat
age
week
period
month
acut
activ
hbv
infect
diagnos
detect
hepat
b
surfac
antigen
hbsag
serum
addit
acut
hepat
hbv
infect
carri
risk
chronic
infect
infect
subsequ
cirrhosi
liver
dysfunct
risk
hepatocellular
carcinoma
develop
chronic
carrier
risk
chronic
infect
invers
relat
age
individu
infect
acquir
infant
infect
birth
likelihood
develop
chronic
diseas
acut
hbv
infect
complic
per
pregnanc
chronic
hbv
found
pregnanc
risk
transmiss
fetu
greatest
matern
acut
hbv
infect
acquir
second
third
trimest
sinc
mother
like
shed
hbv
deliveri
mother
infecti
transmiss
infant
occur
labor
deliveri
unit
state
prior
routin
screen
treatment
newborn
acut
chronic
hbv
infect
acquir
perinat
period
infant
acquir
hbv
like
develop
chronic
infect
cdc
recommend
women
high
risk
acquisit
hbv
infect
receiv
hbv
vaccin
safe
pregnanc
women
expos
hbv
infant
mother
diagnos
hbv
infect
pregnanc
receiv
prophylaxi
hbv
vaccin
hepat
b
immun
globulin
hbig
evid
suggest
administr
hbig
women
third
trimest
pregnanc
prevent
transmiss
hbv
infant
acquir
infect
utero
rather
birth
process
women
test
hbsag
first
prenat
visit
pregnanc
even
previous
test
vaccin
women
previous
screen
high
risk
hepat
b
multipl
partner
std
intraven
drug
use
partner
clinic
hepat
screen
deliveri
women
risk
seroposit
vaccin
hepat
c
viru
hcv
envelop
singl
strand
rna
viru
transmit
transfus
contact
blood
sexual
transmiss
may
occur
clearli
document
hcv
becom
chronic
infect
high
associ
hepatocellular
carcinoma
pregnant
women
unit
state
infect
hcv
diagnosi
hcv
base
serolog
test
follow
confirmatori
serolog
test
qualit
molecular
test
viral
rna
pregnanc
appear
modifi
cours
hcv
mother
acut
hcv
pregnanc
appear
associ
increas
risk
preterm
deliveri
infant
suscept
infect
deliveri
exposur
infecti
viru
birth
process
vertic
transmiss
occur
infant
whose
mother
hcv
rnaposit
mother
hcv
rnaneg
cesarean
deliveri
may
decreas
transmiss
hcv
pregnant
women
histori
iv
drug
use
blood
transfus
organ
transplant
screen
hepat
c
infect
serolog
assay
use
interferon
caus
fetal
growth
retard
ribavirin
teratogen
effect
contraind
pregnanc
studi
unit
state
europ
found
women
childbear
age
colon
group
b
streptococcu
gb
pregnant
women
asymptomat
although
small
number
develop
gb
urinari
tract
infect
chorioamnion
endometr
without
prophylaxi
colon
demonstr
infant
born
colon
mother
major
vertic
transmiss
occur
labor
passag
birth
canal
intrauterin
infect
fetu
appear
follow
ascend
spread
gb
vagina
small
number
infant
may
infect
swallow
infect
amniot
fluid
gbsinfect
infant
may
present
sepsi
pneumonia
mening
osteomyel
septic
arthriti
deliveri
week
gestat
prolong
membran
ruptur
matern
intrapartum
temperatur
increas
risk
earlyonset
gb
diseas
time
prior
implement
guidelin
univers
screen
intrapartum
treatment
support
cdc
american
colleg
obstetrician
sand
gynecologist
acog
american
academi
pediatr
attack
rate
group
b
streptococc
neonat
sepsi
mening
unit
state
per
mortal
year
follow
implement
cdc
guidelin
decreas
rate
earli
infant
age
day
neonat
infect
although
overal
rate
invas
group
b
streptococc
diseas
increas
intrapartum
prophylaxi
affect
rate
late
infant
age
day
infect
major
benefit
prophylaxi
observ
white
infant
contrast
rate
black
infant
rose
gener
incid
invas
group
b
streptococc
infect
twice
high
black
white
rel
risk
time
high
infant
pregnant
women
per
guidelin
pregnant
women
screen
week
gestat
labor
yet
screen
women
screen
earli
retest
week
deliv
specimen
obtain
rectum
vagina
test
gb
either
cultur
method
use
select
enrich
broth
nucleic
acid
amplif
method
women
gb
uti
need
rescreen
recommend
summar
tabl
per
guidelin
infant
week
gestat
appear
healthi
whose
mother
receiv
least
hour
intrapartum
prophylaxi
deliveri
may
discharg
home
hour
outstand
concern
person
compli
home
observ
present
effort
way
develop
vaccin
prevent
invas
gb
diseas
recent
cdc
surveil
data
suggest
pentaval
conjug
vaccin
includ
type
ia
ib
ii
iii
v
could
prevent
neonat
diseas
unit
state
listeriosi
infect
gramposit
bacillu
listeria
monocytogen
often
foodborn
report
highest
mortal
rate
foodborn
pathogen
even
appropri
antibiot
therapi
given
intracellular
pathogen
depend
cellimmun
resolut
infect
seriou
ill
occur
individu
compromis
cellmedi
immun
onethird
report
case
listeriosi
occur
pregnant
women
frequent
third
trimest
although
infect
may
caus
matern
septicemia
often
appar
flulik
ill
prematur
labor
decreas
fetal
movement
initi
site
infect
ingest
usual
intestin
follow
transloc
spread
liver
spleen
replic
occur
although
primari
mode
infect
placenta
gravid
uteru
hematogen
ascend
infect
vagina
may
also
occur
listeria
like
gramposit
organ
bind
immun
cell
receptor
also
present
amniot
epitheli
cell
decidu
inflammatori
cell
placenta
bind
listeria
pregnancyassoci
tissu
may
mediat
part
tlr
express
cell
might
contribut
apoptot
cell
death
placent
tissu
uteru
infect
organ
evad
nonspecif
innat
specif
cellmedi
immun
respons
invas
factor
listeriolysin
phospholipas
c
allow
bacteria
escap
phagocyt
vacuol
form
pore
cell
membran
caus
lysi
vacuol
listeria
abl
replic
cell
cytosol
use
intracellular
actin
polymer
propel
bacteria
one
cell
anoth
cell
minim
exposur
extracellular
environ
listeria
also
express
surfac
protein
call
internalin
enabl
organ
invad
nonphagocyt
cell
includ
placent
syncytiotrophoblast
villou
cytotrophoblast
cell
well
intestin
cell
outcom
placent
infect
pregnanc
loss
fetal
death
preterm
birth
stillbirth
newborn
expos
listeria
may
develop
septicemia
meningoenceph
outbreak
pregnanc
complic
matern
listeriosi
termin
fetal
neonat
death
empir
treatment
ampicillin
amoxicillin
may
improv
outcom
emerg
infect
dengu
dengu
hemorrhag
fever
dhf
seriou
complic
infect
mosquitoborn
dengu
fever
viru
like
follow
primari
dengu
infect
pregnant
nonpregn
women
dhf
may
confus
preeclampsia
symptom
thrombocytopenia
liver
dysfunct
capillari
leak
edema
ascit
decreas
urin
output
pregnant
women
dengu
present
third
trimest
dengu
infect
first
trimest
pregnanc
may
complic
spontan
abort
third
trimest
prematur
deliveri
sever
prolong
bleed
surgic
deliveri
incid
fetal
death
increas
dhf
increas
vascular
permeabl
endotheli
leakag
damag
placenta
may
allow
vertic
transmiss
viru
fetal
malform
appear
associ
matern
infect
howev
exposur
utero
may
predispos
infant
dhf
treatment
support
intraven
fluid
replac
platelet
transfus
need
pregnant
women
avoid
travel
area
ongo
dengu
transmiss
particularli
third
trimest
west
nile
viru
mosquitoborn
flaviviru
infect
human
mammal
includ
hors
dog
cat
alpaca
nonmammalian
speci
bird
allig
mani
speci
mosquito
transmit
viru
infect
placenta
transmiss
fetal
shown
murin
model
vertic
transmiss
wnv
subsequ
enceph
found
liveborn
infant
howev
studi
author
birth
outcom
follow
wnv
infect
pregnant
women
unit
state
clearli
demonstr
relationship
development
abnorm
report
outcom
follow
wnv
infect
pregnanc
includ
case
fetal
growth
retard
dramat
case
chorioretin
scar
brain
abnorm
includ
lissencephali
sever
white
matter
loss
infant
born
mother
infect
wnv
second
trimest
viral
hemorrhag
fever
includ
lassa
fever
ebola
appear
sever
pregnanc
mortal
higher
pregnant
women
infect
lassa
fever
risk
death
highest
third
trimest
placenta
thought
site
viral
replic
women
improv
rapidli
deliveri
termin
pregnanc
ebola
viru
infect
risk
death
similar
trimest
pregnant
women
like
hemorrhag
neurolog
complic
lcmv
arenaviru
caus
zoonot
infect
acquir
contact
rodent
wast
adult
infect
caus
fever
malais
myalgia
anorexia
nausea
vomit
pharyng
adenopathi
cn
diseas
occur
period
improv
intrauterin
lcmv
infect
caus
fetal
death
hydrocephalu
microcephali
macrocephali
chorioretin
neurolog
sequela
psychomotor
retard
deaf
neurolog
find
highli
variabl
may
correl
development
stage
time
infect
diagnosi
made
serolog
pregnant
women
avoid
rodent
excreta
case
infect
pregnant
women
anaplasma
phagocytophilum
previous
ehrlichia
phagocytophilum
describ
sheep
cow
infect
late
pregnanc
report
caus
stillbirth
abort
congenit
infect
recogn
treat
appear
advers
consequ
human
pregnanc
recent
report
review
nine
case
hga
women
week
gestat
pregnanc
affect
sever
ill
congenit
infect
found
one
case
patient
treat
success
either
doxycyclin
rifampin
diseas
due
anaerob
bacterium
clostridium
difficil
often
manifest
diarrhea
may
progress
tabl
intrapartum
prophylaxi
prevent
earlyonset
gb
infect
screen
pregnant
women
week
gestat
unless
gb
bacteriuria
detect
treat
women
whose
cultur
result
unknown
risk
factor
deliveri
week
gestat
prolong
membran
ruptur
hour
matern
intrapartum
temperatur
women
gb
bacteriuria
current
pregnanc
women
previous
gave
birth
infant
invas
gb
treat
women
neg
cultur
obtain
week
prior
deliveri
l
gbscolon
women
undergo
plan
cesarean
deliveri
begun
labor
ruptur
membran
regimen
recommend
l
penicillin
g
million
unit
intraven
dose
follow
million
unit
intraven
everi
hour
deliveri
altern
l
ampicillin
g
intraven
dose
follow
g
intraven
everi
hour
deliveri
penicillin
allergi
l
low
risk
anaphylaxi
l
cefazolin
g
intraven
dose
follow
g
intraven
everi
hour
deliveri
l
high
risk
anaphylaxi
gb
suscept
erythromycin
l
erythromycin
mg
intraven
everi
hour
deliveri
gb
suscept
clindamycin
l
clindamycin
mg
intraven
everi
hour
deliveri
gb
resist
erythromycin
clindamycin
l
vancomycin
g
intraven
everi
hour
deliveri
two
women
infect
appar
new
hypervirul
epidem
strain
design
pcr
ribotyp
north
american
pulsedfield
type
hyperproduc
toxin
b
addit
product
binari
toxin
three
pregnanc
end
stillbirth
six
women
develop
toxic
megacolon
five
underw
colectomi
three
women
ultim
die
women
previous
admit
hospit
least
one
case
known
prior
antimicrobi
treatment
lead
concern
pregnanc
might
predispos
factor
sever
cdi
cytokin
propos
play
role
resolut
cdi
one
hypothesi
suggest
decreas
respons
later
pregnanc
might
coincid
increas
suscept
cdi
four
addit
case
peripartum
cdi
two
case
hypervirul
strain
report
recent
last
case
natur
occur
smallpox
report
somalia
smallpox
remain
concern
potenti
use
agent
bioterror
histor
studi
mortal
rate
gener
much
higher
pregnant
women
reportedli
recent
review
four
larg
studi
period
found
overal
case
fatal
rate
pregnant
women
risk
increas
overal
first
trimest
third
trimest
pregnant
women
also
like
develop
hemorrhag
smallpox
vaccin
offer
consider
protect
mortal
risk
death
smallpox
infect
appear
higher
unvaccin
compar
previous
vaccin
pregnant
women
acut
matern
smallpox
also
devast
affect
pregnanc
outcom
caus
spontan
abort
prematur
termin
pregnanc
overal
proport
abort
preterm
birth
report
half
live
birth
born
mother
infect
second
half
pregnanc
die
within
two
week
deliveri
within
first
hour
risk
miscarriag
preterm
birth
similarli
elev
even
women
mild
case
smallpox
prior
vaccin
appear
improv
pregnanc
outcom
cellular
immun
appear
import
aspect
immun
respons
determin
outcom
sinc
neutral
antibodi
develop
earli
primari
infect
influenc
lesion
size
affect
surviv
anim
model
nonpregn
inbr
mice
experiment
poxviru
infect
vaccinia
murin
poxviru
ectromelia
shown
type
immun
respons
product
cytokin
promot
resist
smallpox
type
respons
enhanc
pathogenesi
smallpox
vaccin
pregnant
women
recommend
set
potenti
outbreak
sinc
vaccin
concept
pregnanc
result
rare
instanc
fetal
vaccinia
risk
small
case
document
despit
massiv
smallpox
vaccin
erad
effort
women
us
militari
enrol
nation
smallpox
vaccin
pregnanc
registri
rate
pregnanc
loss
preterm
birth
birth
defect
increas
case
fetal
vaccinia
antimicrobi
agent
cross
placenta
drug
could
potenti
advers
effect
fetu
avoid
lifesav
circumst
agent
known
safeti
profil
use
whenev
possibl
current
fda
categor
antimicrobi
use
pregnanc
base
evid
safeti
risk
categori
studi
use
pregnant
women
without
known
advers
effect
fetu
categori
b
appear
safe
anim
studi
limit
studi
pregnant
women
appear
safe
human
studi
although
problem
studi
pregnant
anim
categori
c
littl
evid
regard
safeti
harm
pregnant
women
categori
evid
harm
case
benefit
may
outweigh
risk
circumst
categori
x
risk
high
unlik
outweigh
benefit
food
drug
administr
fda
plan
chang
classif
system
near
futur
clinic
descript
antibiot
pregnanc
categori
b
penicillin
includ
beta
lactambetalactamas
inhibitor
combin
cephalosporin
aztreonam
nitrofurantoin
clindamycin
aminoglycosid
drug
gener
consid
safe
pregnanc
sulfonamid
trimethoprim
avoid
agent
avail
drug
affect
folat
metabol
potenti
affect
first
trimest
neural
tube
develop
third
trimest
sulfonamid
lead
neonat
hyperbilirubinemia
kernicteru
women
sulfonamid
caus
hemolyt
anemia
may
poorli
toler
pregnanc
ceftriaxon
also
known
displac
bilirubin
albumin
appear
limit
use
pregnant
women
gfr
increas
pregnanc
dose
drug
aminoglycosid
ceftriaxon
may
requir
adjust
monitor
serum
level
may
assist
dose
vancomycin
aminoglycosid
known
risk
vaccin
pregnant
women
bacteri
vaccin
toxoid
inactiv
viru
vaccin
attenu
live
vaccin
avoid
sinc
potenti
risk
dissemin
fetu
accident
vaccin
liveviru
vaccin
consid
indic
pregnanc
termin
guidelin
cdc
updat
see
tabl
